Trinity Biotech Plc (TRIB) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Trinity Biotech Plc  (NASDAQ: TRIB)


Trinity Biotech Plc's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Trinity Biotech Plc's ROA in the fourth quarter of 2025?
Trinity Biotech Plc recorded a cumulative net loss of $-37 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -36.6%.

However, within the Healthcare sector 540 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 4369.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Total Assets Change -10.47 % 1.46 % 10.18 % 1.46 % 63.23 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -37 -31 -31 -31 -31
Return On Assets (TTM) -36.6 % -29.7 % -29.81 % -30.49 % -30.6 %
TRIB's Total Ranking # 4369 # # # # 4460
Total Assets (TTM) in million 102 102 102 102 114
Seq. Total Assets Change 0 % 0 % 0 % -10.47 % 13.33 %
Seq. Net Income Change - - - - -

TRIB's 5 Years Annual ROA >> Back to TRIB Management Effectiveness >> Compare TRIB ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 7
Sector # 541
Overall # 4331

Return On Assets Statistics
High Average Low
-1.56 %
-27.29 %
-62.03 %
(Dec 31 2021)   (Dec 31 2023)





Financial Statements
Trinity Biotech Plc's Assets $ 102 million TRIB's Balance sheet
Trinity Biotech Plc's Income $ -37 million Quarterly TRIB's Income Statement
TRIB's Income by Division See TRIB's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -10.47 % 63.23 % -33.11 % -20.85 % -12.09 %
Total Assets in million 102 114 70 104 132
Y / Y Net Income Change - - - - -
Net Income in million -37 -31 -37 -44 -2
Annual Return On Assets -36.6 % -27.37 % -52.76 % -41.73 % -1.4 %

TRIB's 5 Years Annual ROA >> Back to TRIB Management Effectiveness >> Compare TRIB ROA to its Competitors



More Return On Assets Ratios
TRIB's' Return on Assets at Yahoo Finance
In Vitro & In Vivo Diagnostic Substances Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TRIB's Roa Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TRIB's Competitors
Subscribers only: Roa for Trinity Biotech Plc's Suppliers
Subscribers only: Return On Assets for TRIB's Customers

You may also want to know
TRIB's Roi TRIB's Inventory Turnover Ratio TRIB's Growth Rates TRIB's Dividend Comparisons
TRIB's Profitability Ratios TRIB's Asset Turnover Ratio TRIB's Dividend Growth
TRIB's Roe TRIB's Valuation Ratios TRIB's Financial Strength Ratios TRIB's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA

Date modified: 2026-07-07T13:58:52+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.